IPC The Hospitalist Company (IPCM) 80.17 $IPCM 39.2%

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
IPC The Hospitalist Company (IPCM) 80.17 $IPCM

39.2% Return Seen to Date on SmarTrend IPC The Hospitalist Call (IPCM)
Comtex SmarTrend(R) - Fri Nov 27, 4:45PM CST
SmarTrend identified an Uptrend for IPC The Hospitalist (NASDAQ:IPCM) on August 3rd, 2015 at $57.59. In approximately 4 months, IPC The Hospitalist has returned 39.21% as of today's recent price of $80.17.
IPCM: 80.17 (+0.01)

IPC The Hospitalist Up 39.2% Since SmarTrend Uptrend Call (IPCM)
Comtex SmarTrend(R) - Fri Nov 20, 1:23PM CST
SmarTrend identified an Uptrend for IPC The Hospitalist (NASDAQ:IPCM) on August 3rd, 2015 at $57.59. In approximately 4 months, IPC The Hospitalist has returned 39.19% as of today's recent price of $80.16.
IPCM: 80.17 (+0.01)

IPC Healthcare Expands Post-Acute Market Presence in the Greater Kansas City Metropolitan Area
GlobeNewswire - Thu Nov 19, 7:00AM CST
IPC Healthcare, Inc. (Nasdaq:IPCM), a leading national acute hospitalist and post-acute provider organization, announced today that it has acquired Heartland Geriatrics, LLC, in Overland Park, Kansas. The acquisition complements IPC's existing market presence for acute and post-acute services in the Kansas City area.
IPCM: 80.17 (+0.01)

Tumi Holdings Set to Join the S&P SmallCap 600
PR Newswire - Wed Nov 18, 4:58PM CST
Tumi Holdings Inc. (NYSE: TUMI) will replace IPC Healthcare Inc. (NASD: IPCM) in the S&P SmallCap 600 after the close of trading on Monday, November 23. Team Health Holdings Inc. (NYSE: TMH) is acquiring IPC Healthcare in a deal expected to be completed on or about that date pending final conditions.
IPCM: 80.17 (+0.01), TUMI: 26.69 (-0.01), MHFI: 107.92 (+1.16), TMH: 43.79 (+0.09)

IPC Healthcare, Inc. Stockholders Approve Acquisition by Team Health Holdings, Inc.
GlobeNewswire - Tue Nov 17, 7:45AM CST
IPC Healthcare, Inc. ("IPC" (NASDAQ:IPCM) today announced that stockholders of IPC formally approved the pending $1.6 billion acquisition of IPC by Team Health Holdings, Inc. Upon completion of the transaction, each share of IPC common stock will convert into the right to receive $80.25 in cash.
IPCM: 80.17 (+0.01)

IPC Healthcare Announces Two Physicians Named ACP Top Hospitalists of 2015
BusinessWire - Mon Nov 16, 7:01AM CST
IPC Healthcare, Inc. (Nasdaq: IPCM), a leading national acute hospitalist and post-acute provider organization, announced today that Kunal Bhagat, M.D., FACP, and Felipe Orellana, M.D., were named two of the nation's Top Ten Hospitalists in the November issue of ACP Hospitalist, a publication of the American College of Physicians.
IPCM: 80.17 (+0.01)

IPC Healthcare Expands Post-Acute Market Presence in Wichita
GlobeNewswire - Fri Nov 13, 7:01AM CST
IPC Healthcare, Inc. (Nasdaq:IPCM), a leading national acute hospitalist and post-acute provider organization, announced today that it has acquired Amity Health, LLC, in Wichita, Kansas. The acquisition complements IPC's existing market presence for acute and post-acute services in the Wichita area.
IPCM: 80.17 (+0.01)

IPC The Hospitalist Shares Up 36.2% Since SmarTrend's Buy Recommendation (IPCM)
Comtex SmarTrend(R) - Thu Oct 29, 3:24PM CDT
SmarTrend identified an Uptrend for IPC The Hospitalist (NASDAQ:IPCM) on August 3rd, 2015 at $57.59. In approximately 3 months, IPC The Hospitalist has returned 36.15% as of today's recent price of $78.41.
IPCM: 80.17 (+0.01)

BUYINS.NET: AFSI, GMAN, DDM, IPCM, FN, BBRG Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Oct 26, 7:08AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of AmTrust Financial Services Inc (NASDAQ:AFSI), Gordmans Stores Inc (NASDAQ:GMAN), ProShares Ultra Dow30 (NYSEDM), IPC The Hospitalist Co Inc (NASDAQ:IPCM), First National Financial Services Ltd (NYSE:FN), Bravo Brio Restaurant Group Inc (NASDAQ:BBRG) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
GMAN: 1.39 (-0.06), FN: 36.71 (+0.34), AFSI: 25.46 (+0.45), IPCM: 80.17 (+0.01), BBRG: 7.79 (+0.01), DDM: 68.83 (+1.72)

IPC Healthcare Expands Market Presence in Chicago
GlobeNewswire - Thu Oct 22, 7:01AM CDT
IPC Healthcare, Inc. (Nasdaq:IPCM), a leading national acute hospitalist and post-acute provider organization, announced today that it has acquired Hospital Medicine Consultants, LLC in Chicago, Illinois. The acquisition complements IPC Healthcare's existing market presence for acute and post-acute services in the northwestern suburbs of the Chicagoland area.
IPCM: 80.17 (+0.01)

IPC Healthcare to Report Third-Quarter 2015 Financial Results
GlobeNewswire - Mon Oct 19, 7:01AM CDT
IPC Healthcare, Inc. (Nasdaq:IPCM), a leading national acute hospitalist and post-acute provider organization, will report its financial results for the third quarter ended September 30, 2015 on Tuesday, October 27, 2015, after the market close.
IPCM: 80.17 (+0.01)

Uptrend Call Working As IPC The Hospitalist Stock Rises 34.6% (IPCM)
Comtex SmarTrend(R) - Wed Sep 30, 11:39AM CDT
SmarTrend identified an Uptrend for IPC The Hospitalist (NASDAQ:IPCM) on August 3rd, 2015 at $57.59. In approximately 2 months, IPC The Hospitalist has returned 34.57% as of today's recent price of $77.50.
IPCM: 80.17 (+0.01)

IPC Healthcare Acquires Tampa-Based Psychiatry Group
GlobeNewswire - Wed Sep 23, 7:01AM CDT
IPC Healthcare, Inc. (Nasdaq:IPCM), a leading national acute hospitalist and post-acute provider organization, announced today that it has acquired the psychiatry practice of Ashit K. Vijapura, M.D. The Tampa, Florida-based practice focuses on providing psychiatry services in both acute and post-acute settings.
IPCM: 80.17 (+0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors of Sage Therapeutics Have Chance to Join Lawsuit

Updated Category News Views 88

Introduction to the Class Action Lawsuit Attention, investors! There's an important opportunity arising for shareholder litigation against Sage Therapeutics, Inc. The legal firm Bronstein, Gewirtz & Grossman, LLC is officially notifying individuals who have invested in Sage Therapeutics about a class action lawsuit that has now been filed. If you have faced substantial...

Continue Reading
FARO Technologies Revolutionizes 3D Metrology with Leap ST

Updated Category News Views 105

FARO Technologies Enhances 3D Metrology with Leap ST FARO Technologies, Inc. (NASDAQ: FARO) is pushing the boundaries of handheld scanning technology with the introduction of the Leap ST. This launch marks a significant expansion of FARO's product portfolio, positioning the company among the few firms offering a comprehensive range of portable 3D metrology solutions. Leap...

Continue Reading
Strong Financial Performance and Growth Strategies at TORM PLC

Updated Category News Views 181

TORM PLC Reports Robust Q3 2025 Financial Results TORM PLC has demonstrated remarkable resilience and adaptability, reporting its strongest quarterly results in 2025. This achievement underscores the effectiveness of TORM's integrated operating model, as highlighted by the CEO. The company continues to prioritize creating long-term value for its shareholders while...

Continue Reading
Manhattan Associates Faces Legal Challenges Amid Shareholder Losses

Updated Category News Views 304

Manhattan Associates Faces Legal Challenges Following Shareholder Loss In recent developments, Manhattan Associates, Inc. (NASDAQ: MANH) is under scrutiny as a class action lawsuit has been filed against the company. This action comes after an alarming drop in shareholder value, amounting to over $4 billion. The lawsuit is pivotal as it involves allegations of misleading...

Continue Reading
BioLife Solutions Announces Upcoming Financial Results

Updated Category News Views 91

BioLife Solutions to Share Key Financial Insights BioLife Solutions, Inc. (NASDAQ: BLFS), a pioneering developer and supplier of bioproduction products and services specializing in cell and gene therapies, is gearing up for a significant event. The company plans to release its financial results for the third quarter of 2024 after market hours on November 12, 2024. This is...

Continue Reading